ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

In Brief: Hood to form Institute for Systems Biology, To Unite Biologists, High-Tech Industry

December 17, 1999

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994